Paget's Disease News and Research

RSS
Paget’s disease of the bone is a chronic ailment affecting the skeleton. Sir James Paget described Paget's disease of bone in 1877 and the disease is named after him. This is a rare disease affecting 1% of the population in the United States. It commonly affects the elderly and nearly 3 to 4% of the population over age 50 are affected.
Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates

FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Bisphosphonates drug may lead to atypical femur fractures in osteoporosis patients: Report

Bisphosphonates drug may lead to atypical femur fractures in osteoporosis patients: Report

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck challenges New York jury decision in federal FOSAMAX retrial

Scientists discover three genes linked to development of Paget's disease

Scientists discover three genes linked to development of Paget's disease

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Extended treatment with active ingredient increases bone volume and calcium content

Extended treatment with active ingredient increases bone volume and calcium content

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Mutant ATPase blocks autophagy partway and causes multi-tissue degenerative disease

Mutant ATPase blocks autophagy partway and causes multi-tissue degenerative disease

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Genta announces financial results for the third quarter of 2009, reduces workforce to cut payroll costs

Genta announces financial results for the third quarter of 2009, reduces workforce to cut payroll costs

FDA approves Reclast (zoledronic acid) for osteoporosis in postmenopausal women

FDA approves Reclast (zoledronic acid) for osteoporosis in postmenopausal women

Discovery of faulty genes could reveal risk of Paget's disease

Discovery of faulty genes could reveal risk of Paget's disease

X-rays help predict permanent bone damage from bisphosphonates

X-rays help predict permanent bone damage from bisphosphonates

Genta Incorporated issued two key U.S. patents for gallium products franchise

Genta Incorporated issued two key U.S. patents for gallium products franchise

Sun Pharmaceutical receives FDA approvals for 4 generics

Sun Pharmaceutical receives FDA approvals for 4 generics

Genta announces initial trial results for novel drug for bone disease

Genta announces initial trial results for novel drug for bone disease